PhD thesis:

J. Burbiel, “2-Azabicyclo[5.3.0]decane und weitere Azasteroidanaloga als neuartige Antimykotika", Hieronymus Buchreproduktions GmbH, München, 2001 (download as pfd)

Review articles:

J. Burbiel,  "Creativity in research and development environments: A practical review", Int. Journal of Business Science and Applied Management 4 (2), 35-51 (2009) (view article (external link))

R. Akkari, J. Burbiel, J. Hockemeyer, C.E. Müller, “Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs”, Curr. Top. Med. Chem. 6 (13), 1375-1399 (2006)

  L. Yan, J. Burbiel, A. Maaß, C.E. Müller, “Adenosine receptor agonists: from basic medicinal chemistry to clinical development“, Expert Opin. Emerging Drugs 8 (2), 537-576 (2003)

J. Burbiel, F. Bracher, “Azasteroids as antimycotics“, Steroids 68, 587-594 (2003)

Patent:

C. Müller,  J. Hockemeyer,  N. Tzvetkov, J. Burbiel, “New 8-ethinylxanthine compounds useful for treating e.g. Parkinson's disease, catalepsy, dystonia, dyskinetic syndrome, restless legs syndrome, migraine, pain, dementia, neurodegenerative disorders, alcohol withdrawal, and stroke”,  WO002008077557A1, Schwarz Pharma AG. (2008)

Original articles (own research):

J. Burbiel, J. Hockemeyer, C.E. Müller,  “Microwave-assisted ring closure reactions: synthesis of 8-substituted xanthine derivatives and related pyrimido- and diazepinopurinediones”, Beilstein Journal of Organic Chemistry 2:20 (2006) (view article (external link))

J. Burbiel, “On the syntheses of dibenzosuberenone and 2,8-dimethyldibenzosuberenone”, ARKIVOC (xiii) 16-21 (2006) (view article (external link))

J. Burbiel, J. Hockemeyer, C.E. Müller, “Synthesis of xanthine derivatives by microwave-assisted ring closure reaction”, ARKIVOC (ii) 77-82 (2006) (view article (external link))

J. Hockemeyer, J. Burbiel, C.E. Müller, ”Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson´s disease”, J. Org. Chem. 69 (10), 3308-3318 (2004)

J. Burbiel, M. Thorand, C.E. Müller, “Improved, efficient synthesis for multigram-scale production of PSB-10, a potent antagonist at human A3 adenosine receptors“, Heterocycles 60 (6), 1425-1432 (2003)

Original articles (co-authorship for compound contribution):

Pekala, E., J. Burbiel, C.E. Müller, "Preparation of enantiopure (R)-hydroxy metabolite of denbufylline using immobilized Lactobacillus kefiri DSM 20587 as a catalyst", Chirality, in press (2009)

Töpfer, M., J. Burbiel, C.E. Müller, J. Knittel, E.J. Verspohl, "Modulation of insulin release by adenosine A₁ receptor agonists and antagonists in INS-1 cells: The possible contribution of ⁸⁶Rb⁺ efflux and ⁴⁵ Ca²⁺ uptake", Cell Biochemistry and Function 26, 833-843 (2008)

J. Iqbal, J. Burbiel, C.E. Müller, “Development of off-line and on-line capillary electrophoresis methods for the screening and characterization of adenosine kinase inhibitors and substrates”, Electrophoresis 27 (12), 2505-2517 (2006)

INT-Reports:

J. Burbiel, M. Jovanovic, S. Römer, “Data Managemen in der Fraunhofer-Gesellschaft - Empfehlungen für die IT-Strategie-Roadmap”, INT-Bericht 206, Euskirchen, Fraunhofer-Institut für naturwissenschaftliche-technische Trendanalysen (2008)

J. Burbiel, “Die Entwicklung der wehrtechnischen FuE-Strategie des Vereinigten Königreichs von 1998 - 2008”, INT-Bericht 205, Euskirchen, Fraunhofer-Institut für naturwissenschaftliche-technische Trendanalysen (2008)

Contributions to books:

J. Burbiel, S. Grigoleit, J. Schulze, “The weighted-bit assessment table of hazardous chemicals”, Fraunhofer Verbund Verteidigungs- und Sicherheitsforschung: Fraunhofer Symposium Future Security : 3rd security research conference Karlsruhe. Ed.: K. Thoma. Stuttgart, Fraunhofer IRB, 287-291 (2008)

Poster presentations:

M. Köse, A. Schiedel, J. Burbiel, C.E. Müller, “Identification of novel non-nucleoside adenosine kinase inhibitors”, Annual Meeting of the German Pharmaceutical Society, October 10-13, 2007, Erlangen / Germany

J. Burbiel, C.E. Müller, “[1,2,4]Triazolo[1,5-c ]quinazolin-2-amines as novel adenosine receptor antagonists”, Frontiers in Medicinal Chemistry, March 12-15, 2006, Frankfurt am Main / Germany (pdf)

J. Burbiel, J. Hockemeyer, C.E. Müller, “New strategies toward the gram scale production of adenosine receptor ligands“, Drugs Fut. 27 (Supp. A): XVIIth Int. Symp. on Medicinal Chemistry (2002) (pdf)

A. Rajabi-Siahboomi, J. Burbiel, S. Moghimi, “The influence of bile salts on drug release from HPMC controlled release matrix tablets“, Pharm. Res. Suppl. 14 (11), 543-552 (1997)

Selected oral contributions:

 “The weighted-bit assessment table of hazardous chemicals”, Annual Meeting of the German Pharmaceutical Society, Bonn, October 8, 2008

“Microwave assisted synthesis of adenosine receptor ligands”, Symposium on Microwave Accelerated Synthesis, Düsseldorf, September 15, 2005

“Microwave assisted syntheses of adenosine receptor ligands”, Joint Meeting of the Austrian, Czech & German Pharmaceutical Societies, Regensburg, October 7, 2004